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Multi-component powder blends are critical components of numerous process trains across 
a wide variety of manufacturing sectors. Solid dosage forms manufactured from powder 
blends compose a large proportion of pharmaceutical production [1].  Pharmaceutical 
powder blends are composed of a drug substance (active pharmaceutical ingredient) and 
inactive excipients to aid processing, stability and delivery [2].  Drug load is an important 
factor to be considered during the design of these blends. The higher the drug load, the 
higher the probability of the drug’s properties impacting the blend’s manufacturability and 
finished dosage form properties. For instance, Wenzel et al. showed how the increase of 
drug load negatively affected granulation, compression, tablet disintegration and dissolution 
[3]. In contrast to a gradual change in blend properties with increasing drug load, a 
threshold drug concentration was proposed, referred to as the percolation threshold [2]. It 
is proposed that issues can be expected to occur in manufacturability and drug product 
quality above the percolation threshold concentration of drug [2,4]. In terms of a quality by 
design (QbD) approach to pharmaceutical development, the percolation threshold model 
can aid identification of a threshold level drug above which of critical quality attributes of 
the formulation are undetermined. Knowing the percolation threshold drug level can aid 
robust  formulation development by maintaining the drug below this threshold.  
Percolation is a geometrical-statistical theory that includes two model types: (1) lattice 
model, and (2) continuum model.  The lattice percolation model has been previously 
reported in the literature as appropriate to model tablet tensile strength for systems 
containing microcrystalline cellulose [5-8]. In a lattice model, percolation threshold is 
















substance [5].  Consider initially a matrix of A being percolated by particles of B. As the 
concentration of B increases in the system, a threshold concentration will be reached and a 
property phase transition will be noticed. Above this threshold the system is a matrix of B 
percolated by particles A. The property phase transition occurs because of the formation of 
clumps of particle B that are connected or close enough to each other in such a way that 
they are linked across entire volume of the tablet, i.e. forming an infinite cluster. This theory 
can be extrapolated to the random distribution of a group of substances A in a lattice 
formed by a group of substances B [9]. In this case, the substances that form the group A 
need to have at least one similar property and at the same time this property must be 
dissimilar to the substances of group B. For example, in a tablet blend, drug substance and 
excipients that have poor flow could be grouped together as A, while all the substances 
within the formulation that have good flow would belong to group B.  
Percolation threshold theory outputs a concentration range where the property analysed 
undergoes a sudden change, which can be observed as an edge of failure. From this theory 
it is possible to predict the blends that would present suboptimal properties and thereby 
determine an optimum drug concentration range to achieve blends designs that are robust 
with respect to those properties. Percolation threshold theory is mathematically described 
by the power law of Equation 1,  
𝑋 = 𝐾1∗(𝜌 − 𝜌𝑐)
𝑞 Equation 1 
 where 𝑋 is one property observed (e.g. tablet strength, drug release, compactibility or 
electrical conductibility) [10-13]. The constant 𝐾1∗ is a proportionality constant or scaling 
factor, ρ is the occupation probability, 𝜌𝑐 represents the percolation threshold and q is a 
















One of the critical quality attributes to consider during the development of a tablet blend 
for compaction is the tablet’s tensile strength. Tensile strength is defined as the resistance 
of a material to undergo fracture under tension [14]. It is considered a key physical property 
to ensure the quality of manufactured tablets. Tablets are required to have a minimum 
value of tensile strength to remain intact throughout downstream processing and handling. 
On the other hand, an increase in tensile strength can lead to an increase in the dissolution 
time [15]. The application of the percolation threshold model to tablet tensile strength 
provides valuable information in relation to blend design. The main input of this model is 
the tablet relative density, which replaces ρ in Equation 1. Tablet relative density is a 
parameter that is related to a number of individual raw material characteristics, process 
parameters and many subsequent tablet physical properties. The inclusion of tablet relative 
density makes this model a highly practical theory.  
Percolation thresholds have been estimated graphically in a number of previous studies; for 
binary blends of MCC and mannitol [16], for binary blends at different size ratios and for 
different grades of HPMC blended with hydrocortisone [17],  and for complex blends of 
mefenamic acid and a range of excipients [18]. Kuentz and Leuenberger proposed a 
mathematical approach in which the percolation threshold of a blend of microcrystalline 
cellulose (MCC) and paracetamol was modelled [8]. The authors recommended additional 
investigation to confirm their findings. However, there are limited publications in which the 
percolation threshold is predicted mathematically in the field of pharmaceutical sciences. 
Busignies et al. [19] showed that if the mathematical approach is selected, it is necessary to 
begin with modelling the percolation coefficient in order to be able to model the 
percolation threshold for each specific formulation, as the percolation coefficient did not 
















The aim of this study was to define the percolation coefficient for a blend comprising 
MCC/ibuprofen based on a modified Heckel equation [5]. Having determined the 
percolation coefficient for the blend, Equation 1 was then employed to calculate the 
respective percolation thresholds. The blend considered contained a model drug, ibuprofen, 
and a commonly used excipient, MCC. These binary blend components were selected 
because ibuprofen exhibits poor flowability and compressibility and is prone to capping  [20-
22]. MCC is a widely used excipient due to its good flowability, high dilution potential and 
compactibility [23]. Therefore, the contrasting properties qualifies the combination of these 
substances as an appropriate case to apply the percolation model. Particle pore and particle 
shape can have significant impact on percolation threshold [24-26], therefore, two MCC 
grades with differing particule properties were investigated in this study: Vivapur® 102, an 
air streamed dried grade, and Emcocel® 90, a spray dried grade. Raman image analysis of 
compacted blends was employed to visually determine whether an infinite cluster of drug 
could be detected on the surface of tablets prepared above the percolation threshold. 
Properties of the powder blends and the tablets manufactured were investigated using 
univariate and principal component analysis (PCA) analysis to determine properties which 
are diminished above the percolation threshold and investigate if PCA is able to identify the 
















2. MATERIALS AND METHODS 
2.1 Materials  
Microcrystalline cellulose (Vivapur® 102, and Emcocel® 90) was supplied by JRS PHARMA 
Gmbh+Co. KG, Germany. Ibuprofen was obtained from Kemprotec Ltd., United Kingdom.  
2.2 Methods 
2.2.1 Powder characterization 
2.2.1.1 Surface area 
MCC samples were degassed for 3 h, at 120 oC and ibuprofen samples for 24 h, at 40 oC in a 
FlowPrep 060 sample degas system (Micromeritics, USA). The mass of each sample was 
between 0.4 - 0.6 g. Surface area was determined using a Gemini VI surface area and pore 
size analyser (Micromeritics, USA). The modelling equation applied was the Brunauer 
Emmett-Teller equation (BET) [27]. Liquid nitrogen at - 196 oC kept isothermal conditions 
and N2 was the absorbate gas utilized. The analysis were carried out in triplicate.  
2.2.1.2 Laser diffraction particle sizing  
Particle size distribution was measured using a particle size analyzer (Mastersizer, Malvern 
Instruments, UK). A dry powder method was employed. Laser obscuration was controlled to 
a maximum of 5 %, and the feeding was set to a rate of 20 % for MCC and 35 % for 
ibuprofen, both at 1.5 bar. The height of the feeder was set to 2.5 cm. Measurements were 
taken for a period of 10 seconds, in triplicate.  
















Microcrystalline cellulose moisture content was quantified using thermogravimetric analysis 
(TGA) (TA Q500 TGA, TA instruments, USA). N2 was used as the controlled atmosphere. 
Samples between 5 - 7 mg were loaded on the platinum pan. A ramp operation module was 
set up following a heating rate of 10 oC/min up to 270 oC. The weight loss measured was 
assumed to be moisture loss as no other thermal events occur in MCC between 0°C and 
120°C as confirmed by differential scanning calorimetry (DSC).  
2.2.1.4 Morphology 
MCC morphology was characterized using a Malvern Morphologi G3® particle 
characterization system (Malvern Instruments, Malvern, UK). This instrument allows 
characterization of the shape, form and size of particles. A sample volume of 7 mm3 was 
automatically dry-dispersed by the Sample Dispersion Unit (SDU) which injects compressed 
air for 20 ms at 1 bar through the sample, onto a glass plate. A settling time of 60 seconds 
was held between the air injection and presentation of the sample for analysis. Malvern 
Morphologi G3® recorded individual pictures of particles and these images were acquired 
over 3 circular areas of the plate. The size parameters analysed were circle equivalent (CE) 
diameter, length and width, and the shape parameter analysed was aspect ratio. 
CE diameter is the correspondent diameter of a circular particle with the same area as the 
particle analysed. Aspect ratio is given by dividing width by length for each particle. Particles 
with an aspect ratio below 0.5 were classified as needle-shaped.   
2.2.1.5 Scanning electron microscopy (SEM) 
Scanning electron microscopy (SEM) was used to obtain images of Vivapur® and Emcocel®. 
















size of the samples were measured using an electron beam source. The voltage was 
constant at 3 kV. Samples were gold coated in SEM gold coater (Jeol, UK) prior to analysis to 
prevent charging of the samples by the SEM electron beam. A coating time of approximately 
45 seconds was used to deposit a thin layer onto the samples. 
2.2.2 Blend preparation  
Binary blends of ibuprofen and Vivapur®, and ibuprofen and Emcocel®, were prepared at 
concentrations between 2.5 and 40 % w/w ibuprofen in MCC. A total of 300 g of each 
formulation was blended in Cube Mixer KB, ERWEKA (Universal Gear UG, Germany) at 30 
rpm for a duration of 30 min.   
2.2.3 Blend characterization 
2.2.3.1 Bulk and tapped densities 
Bulk and tapped densities were calculated as outlined in the European Pharmacopoeia (Ph 
Eur 9.0) [28]. A 100 ml cylinder was filled up to the mark with powder of a known mass, and 
the bulk density (ρbulk) was calculated by dividing the mass of the powder by the volume of 
the cylinder. The loaded cylinder was then placed in a SVM 122/222 tapped density tester, 
(Erweka GmbH.). The cylinder was tapped 500 and 750 times which compacted the powder 
by removing air from voids within the sample. The tapped density (ρtapped) was calculated by 
dividing the powder mass by the final volume that the powder occupied in the graduated 
cylinder.  
















The true density (ρtrue) of materials was measured using a helium pycnometer Accupyc 1330 
microprocessor controlled gas pycnometer (Micromeritics, USA). The jar volume was 11.2 
cm3 and weight of the samples was 2 g. The results presented are the average of ten 
measurements. The relative density of powder blends (ρrelative) was calculated by dividing 
ρbulk from Powder Flow Tester by ρtrue. 
2.2.3.3 Flowability and compressibility 
Flowability was determined by the calculation of the Hausner ratio (HR) (Equation 2) using 




 Equation 2 
Hausner ratio measures the loose and dense packing conditions that the powder is 
subjected [28, 29].  
Powder flowability classification was also determined using an annular shear cell tester, 
Powder Flow Tester (PFT), Brookfield Engineering Laboratories, Inc., USA. This methodology 
is considered to be a more consistent and reliable method to determine powder flow 
compared to the Hausner ratio. The Hausner ratio can be variable depending on the 
procedure employed [29-31]. A vane lid was used in order to perform a standard flow 
function test. The cell volume of 43 cm3 was chosen and the mass to fill up the cell varied 
from 14 to 16 g across the different formulations. The major principal consolidation stresses 
were defined in a geometric progression that resulted in values of between 0.02 to 6.07 KPa 
for MCC and 0.02 and 2.98 KPa for ibuprofen. The maximum principal consolidation stresses 
















Compressibility was determined for each blend using the same set up as the flowability test, 
however the consolidation stresses were approximately between 0.02 and 25.5 KPa and a 
flat lid was used. The results were expressed as bulk density vs. major principal 
consolidation stresses [32].   
2.2.4 Direct compression 
The formulations were directly compacted to form round and flat tablets with 8 mm 
diameter and weight of 270 ± 10 mg in a ten station rotary tablet press (Riva™ Piccola, 
Argentina), at a speed of 20 rpm. The relative air humidity was 50 ± 5%. The compaction of 
each blend was performed under 14 different compaction pressures, between 
approximately 20 and 400 MPa. After compaction the tablets were stored for 48 hours 
under ambient conditions before further analysis.  
2.2.5 Tablet characterization  
Tablets hardness, weight, thickness and diameter were measured using a semi-automatic 
tablet testing system, SmartTest 50 (Sotax, Switzerland) (N=20 per blend). Tablet envelope 
density, (ρtablet) was obtained by dividing tablet weight by tablet volume. Tablet relative 
density, ρ, was calculated by dividing the tablet envelope density by the true density 
obtained from the annular shear cell tester for the respective powder formulation, 




  Equation 3 
2.2.6 Heckel Analysis  
The Heckel model was used to calculate the yield pressure, 𝑃𝑦𝑖𝑒𝑙𝑑 = 1 (3 ∙ 𝐾)⁄ , for each 



















) = 𝐾 ∙ 𝑃 + 𝐴 Equation 4 
where ρ is the tablet relative density, P is the compaction pressure, A is a constant that 
represents the degree of packing that can be achieved by rearrangement of particles, i.e., 
before considerable inter-particle bonding take place, and K is a constant related to the 
ability of the powder to undergo plastic deformation. 
 
2.2.7 Percolation coefficient and percolation threshold 
Tablet tensile strength (σT) was calculated from measured thickness (T), diameter (D), and 
hardness (H) using Equation 5 [14].   
 𝜎𝑇 =
2 ∙ 𝐻
𝜋 ∙ 𝐷 ∙ 𝑇
 Equation 5 
The percolation coefficient (Tf) when it is calculated for tensile strength was modelled using 
a modified Heckel equation proposed by [34]. This is given by the simplified Equation 6, in 




T PK   
Equation 6 
The percolation threshold, ρc (AB), as a critical solid fraction, was determined by the linear 
correlation between tablets relative density (ρ) and fTT
1
 , expressed by Equation 7, for each 







ABK cTTT ff    Equation 7 
As ρc (AB) and fTK
1

















1 𝑇𝑓⁄ = 𝑎 ∙ 𝜌 + 𝑏 Equation 8 
Thus, the percolation threshold could be calculated considering the point where 𝜎𝑇
1/𝑇𝑓 = 0, 
i.e. Equation 9. 
 𝜌𝐶 (𝐴𝐵) =
−𝑏
𝑎
 Equation 9 
The values of the percolation threshold of each blend, ρc (AB), were then used to obtain two 
other percolation threshold values 𝜌𝐶 (𝐴) and 𝜌𝐶 (𝐵) (Equation 10). While 𝜌𝐶 (𝐵) represents 
the minimum relative density, or solid fraction, above which there is a change in tensile 
strength behavior, 𝜌𝐶(𝐴) is related to the dilution capacity of substance A, i.e. 
microcrystalline cellulose. Thus, 𝜌𝐶 (𝐴) provided the fraction of ibuprofen that could be 
loaded into the blend with MCC in such way that MCC still leads the overall properties of the 
blend. 
 𝜌𝑐(𝐴𝐵) = 𝑋𝐴 ∙ 𝜌𝑐(𝐴) + (1 − 𝑋𝐴) ∙ 𝜌𝑐(𝐵) Equation 10 
A dilution capacity model was applied in order to express the 𝜌𝐶 (𝐴) in terms of mass 
fraction (Xc), Equation 11 [8]. This conversion was performed as dilution capacity is an 
useful parameter to consider when designing  a pharmaceutical  tablet formulation. 







− ∅ Equation 11 
In which ϕ and φ are parameters dependent of the true density of substances A (MCC) and 



















 Equation 12 
 𝜑 =
−2 ∙ 𝜌𝑐(𝐴) ∙ 𝜌𝑡𝑟𝑢𝑒(𝐴) − 𝜌𝑡𝑟𝑢𝑒(𝐵)
𝜌𝑐(𝐴) ∙ [𝜌𝑡𝑟𝑢𝑒(𝐴) + 𝜌𝑡𝑟𝑢𝑒(𝐵)]
 Equation 13 
 
2.2.8 Raman Spectroscopy  
Raman imaging was carried out using a RA802 Pharmaceutical Analyser (Renishaw, UK). 
Placebo tablets were first analysed and reference spectra of Vivapur® and Emcocel® were 
generated by averaging map datasets. A reference spectrum of ibuprofen was also acquired.  
All tablets were measured using StreamLineTM software package. Each tablet was measured 
using a 785 nm line-focussed laser to acquire approximately 76,000 spectra over an area of 
8.3 mm x 8.3 mm. A measurement step size of 30 µm was used and each tablet took 15 
minutes to measure. Raman images were generated using non-negative least squares 
(NNLS) component analysis and reference spectra for ibuprofen and the two forms of MCC.  
 
2.2.9 Multivariate analysis 
Multivariate analysis (MVA) is increasingly being used in pharmaceutical sciences [35]. 
Chemometrics methods, such as principal component analysis (PCA), are used to simplify 
data visualization, classify samples and predict variables. PCA was performed to investigate 
whether this technique could distinguish the behaviour of the blends below and above the 
percolation threshold, and, also to determine if there are differences between blends 
containing Vivapur® compared to those containing Emcocel®. Principal component analysis 
(PCA) was performed using Origin data analysis and graphing software (OriginLab, USA). The 
algorithm used was the singular value decomposition with full cross validation for all the 
















input into the model. The first was the mean value of each predictor, the second is the 
mean minus its standard deviation and the third is the mean plus its standard deviation. The 
optimal number of components was three, which explained 95.51% of the variance in the 
total data input. The results were represented graphically by bi-plots, i.e. scores and 
loadings plotted in one single graphic. The scores represent the distance of each sample 
from the mean of all samples along each PC, therefore, blends (scores) located in close 
proximity are similar. The loading plot explains which variables are responsible for grouping 




3.1 Powder characterization  
The particulate and bulk properties of both MCC grades and ibuprofen are summarised in 
Table 1. Particle size distribution determined using laser diffraction particle size analysis 
showed that Vivapur® had a slightly greater volume of particles with a larger particle size in 
comparison to Emcocel® (Figure 1a) and hence a larger D50 value (Table 1). A second particle 
size analysis method, the Morphologi G3® which determines particle size distribution and 
shape using statistical image analysis, clearly showed that the Vivapur® sample contained a 
greater percentage of particles with a larger circle equivalent (CE) diameter in comparison 
to Emcocel® (Figure 1b). Despite containing larger particles, as shown by laser diffraction 
particle sizing and CE, Vivapur® sample was also determined to have a significantly higher 
surface area in comparison to Emcocel®. An inverse relationship between particle size and 
surface area was not observed as MCC has a highly porous structure, as observed in the SEM 
















therefore there is no relationship between particle size and surface area.  A pronounced 
difference in the morphology between the two grades of MCC was also observed when the 
aspect ratio was analysed by the Morphologi G3®. The percentage of needle shaped 
particles of Vivapur® sample was 51%, while for Emcocel® sample this value was 34%. The 
model drug, ibuprofen, showed dissimilar properties to microcrystalline cellulose samples, 
exhibiting a smaller particle size distribution and surface area (Table 1, Figure 1a). 
The true, bulk, tapped and relative densities of both MCC samples were similar (Table 1). 
Figure 3a shows that both MCC samples displayed similar powder compressibility with 
increase in consolidating stress. In comparison to MC , the relative density and 
compressibility of ibuprofen was greater. Compressibility as a function of tapped and bulk 
density confirmed the findings. Both MCC grades exhibited good flowability, as expressed by 
Hausner ratio and flow function coefficient (Table 1). Ibuprofen was classified as cohesive 
when expressed by Hausner ratio and by flow function coefficient [36, 37]. Ibuprofen/MCC 
blends were characterized in terms of density, flow and compressibility properties (Table 2, 
Figure 3b, 3c). It was observed that an increase in drug content resulted in increased bulk 
and relative density and poorer flow properties, as indicated by the blend Hausner ratio and 
powder flowability classification.   
 
3.2 Blend behaviour during tabletting 
Ibuprofen/MCC blends with ibuprofen content between 0 % and 30 % w/w were compacted 
and tensile strength calculated with respect to compaction pressure. Formulations 
containing 40% w/w ibuprofen/MCC could not be tabletted due to poor flow from the 
hopper and incomplete filling of dies. Tabletability profiles (Figure 4) showed that both 
















compaction pressures. As ibuprofen concentration was increased, a drop in tablet tensile 
strength was observed. Tablet weight variability, expressed as % relative standard deviation 
(%RSD) increased for blends with 20 % w/w ibuprofen and above (Figure 5). Increase in 
weight variability was attributed to a deterioration in blend flow and this behaviour is in 
agreement with blend flow behaviour measured for these blends (Table 2).  
 
3.3 Percolation threshold modelling 
Compaction pressures between 20 MPa to 60 MPa were selected to model percolation as 
the rearrangement of the particles inside the die, the phenomenon of interest, occurs at 
lower pressures. The modified Heckel model proposed by [34] (Equation 6) was applied for 
each ibuprofen/MCC blend and the respective percolation coefficient calculated (Table 3). 
No significant difference was observed between the percolation coefficients determined for 
blends prepared from Vivapur® and Emcocel® (t-value = 0.78, p-value of 0.449, p-value > 
0.05). Therefore, the global mean of the individual percolation coefficients was calculated 
(𝑇𝑓 =3.5 ± 0.2) and used to determine the percolation threshold. 
The linear correlation of Equation 8 is shown in Figure 6. The percolation threshold, ρc (AB), 
was determined for each blend according to Equations 8 and 9, using the empirical 
coefficient of 3.5 (Figure 7, Table 4). The minimum relative density required to produce 
tablets with significant strength, 𝜌𝐶 (𝐵), and solid fraction 𝜌𝐶 (𝐴) related to the dilution 
capacity of substance A (MCC) were calculated by fitting the mass fraction of MCC. Table 5 
lists the value of 𝜌𝐶(𝐵) expressed by the threshold relative density where there is a change 
in tensile strength behaviour. The values of 𝜌𝐶(𝐵) were 0.646 and 0.704 for blends of 
Emcocel® and of Vivapur®, respectively. Plots of tensile strength vs. relative density of all 
















behaviour at the predicted relative density of approx. 0.70. This behaviour is shown for 
selected blends in Figure 8.  
Values of were used to convert the solid fraction results into mass fraction, Xc. Finally, the 
critical mass fraction (Xc) was calculated from 𝜌𝐶(𝐴) using Equation 11. The Xc values 
obtained for Emcocel® and Vivapur® were 17.76 % w/w and 19.08 % w/w ibuprofen, 
respectively. The percolation thresholds and the critical mass fractions were also calculated 
by applying a theoretical value of percolation coefficient previously published (𝑇𝑓 = 2.7) [10] 
to the Equation 8. This theoretical percolation coefficient was proposed for binary mixtures 
in which one of the substances compacts well and the second is poorly compactable, which 
would apply to the ibuprofen/MCC blends. A comparison of percolation threshold values 
obtained using the empirical value and theoretical value is reported in Table 5.  
 
3.4 Properties behaviour above and below the thresholds  
Raman imaging showed how ibuprofen and MCC particles were distributed at the surface of 
the tablets (Figure 9). At drug concentrations below 15 % w/w drug the drug was distributed 
within a MC matrix. Significant sized clusters were observed at the concentration of 15 % 
w/w, however they do not form a complete pathway able to link entire surface of the tablet. 
At 20 % w/w a phase transition was noticed. As predicted by the percolation threshold 
model, there was an infinite cluster of ibuprofen particles at the surface at drug 
concentrations of 20 % w/w ibuprofen. The properties of the blend are majority ruled by 
material that forms an infinite cluster, i.e. by the ibuprofen above the threshold and by MCC 
















PCA summarised the experimental data collected during the development of the model, 
classified the samples into different groups, and identified the variables responsible for the 
variance between the samples.  
Initially the data was grouped into three groups (1) Microcrystalline cellulose, which 
comprises the placebo samples, (2) Blends Above Threshold (concentrations of > 20 % w/w 
API), and (3) Blends Below Threshold (concentrations of < 20 % w/w API). In Figure 10a, 
scores of blends above the percolation threshold showed negative correlation to tensile 
strength (TS) loadings for all the pressures, therefore, above the threshold lower strength 
tablets was observed. In contrast, Hausner ratio (HR) and compressibility (ΔBD) showed a 
positive correlation to blends above the threshold, which means high compressibility and 
poor flowability. These relationships in compressibility and flowability highlighted by PCA, 
was also noted by univariate analysis of data (Table 2). Low porosity (Po) at different 
compaction pressures and true density (TRD) showed to be highly correlated with Blends 
Above Threshold, which highlights that tensile strength was not improved with the 
reduction of porosity for the blends studied. The confidence interval of the groups Blends 
Below Threshold and Blends Above Threshold overlapped. This showed that PCA was not 
able to precisely predict a threshold drug concentration. Placebo samples showed a clear 
clustering represented by the group Microcrystalline cellulose. The separation of the 
placebo from the blends was explained mainly by the higher tensile strength and lower 
values of tapped (TAD), bulk (BD) and relative (RD) densities.  
Figure 10b shows the second data grouping, which provides an overview of the differences 
between blends prepared with Vivapur® and blends prepared with Emcocel®. PC-3 
differentiated these blends, to some degree (Figure 10b). There is an overlap between the 
















different grades of MCC separate from one another at higher drug loadings. This is 
surprising and may highlight that despite both MCC grades exhibiting similar properties, at 
high drug loadings their interaction with the drug differs in the blend resulting in small 
differences in density parameters. Overall, Emcocel® blends had slightly higher porosity and 
tensile strength. They also showed slightly higher tapped, relative and bulk densities, and 
were less compressible than those containing Vivapur®.  
 
4. DISCUSSION 
The percolation coefficient value determined in this study (𝑇𝑓 = 3.5) was higher than the 
theoretical coefficient (𝑇𝑓 = 2.7) published by [10]. According to [19], the percolation 
coefficient is dependent on the excipient and does not present a universal character. Thus, a 
difference between theoretical and empirical percolation coefficients was expected to 
occur. Other empirical strength percolation coefficients available in the literature are 𝑇𝑓 =
 3.2 for paracetamol and MCC (Avicel PH101) [8], 𝑇𝑓 = 2.1 for Lactose, 𝑇𝑓 = 3.8 
microcrystalline cellulose, and magnesium stearate [19], 𝑇𝑓 = 4.6 for lactose powder, and 
𝑇𝑓 = 6.6 for lactose granules [38], and , 𝑇𝑓= 3.89 for colloidal silica [39]. The percolation 
threshold coefficient has not been published for ibuprofen/MCC blends. Moreover, it was 
observed that other coefficients reported in the literature follow the same trend of being 
slightly greater than the theoretical coefficient. 
In this study the percolation coefficient was modelled from compaction pressure and tensile 
strength, which can be easily measured. Also, the coefficient calculated could be generalised 
for both grades of MCC, as there was no statistically significant difference between the 
















not vary for blends of the same substances, even though there may exist morphological 
differences (particle size and shape). 
The percolation threshold determined for the binary blends with Vivapur® 102 and 
Emcocel® 90 differed marginally, with values of 0.1884 and 0.1718, respectively. Percolation 
theory explains that the threshold is a range of values close to the modelled percolation 
threshold, but it is not possible to determine how close [9]. Therefore, the slight difference 
in pc between different MCC grades may be negligible. The critical mass fraction calculated 
using the theoretical coefficient resulted in higher values, 23.54 % w/w and 24.68 % w/w for 
blends of Emcocel® and of Vivapur®, respectively. However, the flow behavior and Raman 
imaging showed experimentally that the threshold happens between 15 % and 20 % w/w 
ibuprofen. The Raman technique used gave information on the drug distribution on the 
tablet surface. In future studies it would be useful to consider techniques such as 3D 
tomographic technologies, e.g. X-ray Computational Tomography or a 3D Raman model to 
confirm whether the infinite cluster observed on the surface extended throughout the 
structure. Overall, ideally, the coefficient should be calculated for each powder blend, 
rather than considered as a theoretical universal value. 
Blends below the critical mass fraction (≤ 15 % w/w) showed good powder flowability, which 
is characteristic of microcrystalline cellulose. On the other hand, blends above the critical 
mass fraction (≥ 20 % w/w) presented cohesive character, as the ibuprofen powder. Raman 
images were used to investigate ibuprofen domains in the tablets and showed for the first 
time ever, the visualization of the phase transition predicted for tablets using the 
percolation threshold model. For the blends analysed, this phase transition was observed 
















ibuprofen domains connected to each other was observed at the concentration of 20 % 
w/w.  
When the critical concentration has been estimated graphically [16-18], it was a 
retrospective methodology and had to be modelled for data from more complex analysis, 
e.g. dissolution. This more complex analysis would also include failure systems (above the 
threshold) that would need to be carried out unnecessarily. Due to advances in data 
processing software packages since the earlier paper [8] it is no longer challenging to model 
the percolation threshold mathematically. The advantage of modelling the percolation 
threshold mathematically is that this is a predictive tool. Flowability behaviour and tablet 
tensile strength could be predicted in this study based on a simple model that was only 
dependant on compaction pressure, tensile strength, and relative density. The other 
numerous characterization techniques used in this study had the aim to prove the values 
modelled, and investigate differences between the two different grades of MCC; they are 
not necessary for the percolation threshold model. Therefore, the percolation threshold 
model showed in this study represents a simplified mathematical predictive tool that can 
easily be applied for different formulations.  
Principal Component Analysis was not able to identify a clear threshold level with increasing 
drug loading. However, PCA was able to summarize all the data collected and aided in 
clarifying differences between the blends according to the drug loading, and differences 
between the blends containing Vivapur® and the blends containing Emcocel®. Low porosity 
strongly and negatively correlated to blends with high drug loading which confirms that the 
porous regions present in the MCC placebo matrix, were occupied by particles of ibuprofen 
















only captured a small difference between Vivapur® and Emcocel® blends. The most 
expressive difference between these two groups along PC-3 were bulk, tapped, and relative 
densities, which are related to the morphological differences between both grades of MCC, 
captured in the SEM and Morphologi G3® analysis.    
 
5. CONCLUSION  
In this study a percolation coefficient for an ibuprofen/MCC combination was successfully 
modelled and the value obtained (𝑇𝑓 = 3.5) was consistent with earlier reported values for 
similar drug/excipient combinations. Dilution capacities of 19.08 % w/w and 17.76 % w/w 
ibuprofen were calculated for both Vivapur® and Emcocel® blends, respectively. A change in 
blend behaviour above the threshold value was confirmed by experimental flow data. Also 
Raman imaging confirmed the presence of infinite clusters of drug on the tablet surface 
above the threshold value.  The minor differences in physical properties between MCC 
grades did not result in significantly different dilution capacities. PCA analysis of the data 
was not able to identify a clear threshold level with increasing drug loading. The modelling 
approach used in this study can be applied to early formulation development studies to 
identify optimal drug loading for robust pharmaceutical blend processing.   
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Table 1. Particulate and bulk powder properties of Vivapur®, Emcocel®, and ibuprofen. Average values are shown ± standard deviation. 
Property Emcocel® Vivapur® Ibuprofen 
D10 (μm) (n=5) 30.0 ± 0.25 31.1 ± 0.30 16.5 ± 0.08 
D50 (μm) (n=5) 111.6 ± 0.73 118.0 ± 1.60 54.9 ± 0.21 
D90 (μm) (n=5) 236.8 ± 1.55 240.0 ± 2.17 129.0 ± 1.09 
Surface area (m2/g) (n=3) 1.32 ± 0.01 1.37 ± 0.01 0.22 ± 0.02 
True density (g/cm3) (n=10) 1.58 ± 0.00 1.57± 0.00 1.12 ± 0.00 
Bulk density (g/cm3) (n=3) 0.33 ± 0.00 0.31 ± 0.00 0.36 ± 0.01 
Relative density  0.21 0.20 0.32 
Tapped density (g/cm3) (n=3) 0.43 ± 0.01 0.40 ± 0.00 0.57± 0.01 
Hausner Ratio 1.32 (easy flowing) 1.32 (easy flowing) 1.58 (cohesive) 

























Hausner Ratio Flow character 
2.5 0.34 0.43 1.52 0.22 1.26 Easy flowing 
5 0.34 0.45 1.51 0.23 1.30 Easy flowing 
10 0.34 0.44 1.49 0.23 1.28 Easy flowing 
15 0.35 0.46 1.47 0.24 1.32 Easy flowing 
20 0.35 0.47 1.45 0.24 1.36 Cohesive 












Hausner Ratio Flow character 
2.5 0.33 0.42 1.53 0.22 1.27 Easy flowing 
5 0.33 0.43 1.52 0.22 1.30 Easy flowing 
10 0.33 0.43 1.48 0.22 1.30 Easy flowing 
15 0.32 0.44 1.47 0.22 1.34 Easy flowing 
20 0.34 0.46 1.45 0.23 1.36 Cohesive 
















Table 3. Percolation coefficient (Tf) values calculated for each Ibuprofen/MCC blend. r refers to 
Pearson’s correlation coefficient.  
Ibuprofen (% w/w) 
Vivapur® Emcocel® 
Tf r Tf r 
0% 2.96 0.997 3.23 0.996 
2.5% 3.23 0.996 3.29 0.979 
5% 3.57 0.994 3.81 0.995 
10% 3.52 0.996 3.80 0.996 
15% 3.51 0.996 3.67 0.998 
20% 3.62 0.997 3.66 0.995 
30% 3.70 0.997 3.41 0.998 
 
Table 4. Critical solid fraction, ρc (ab), for each blend with increase in Ibuprofen concentration. r 




ρc (AB) r ρc (AB) r 
1 0.1564 0.9996 0.1694 0.9999 
0.975 0.2076 1.0000 0.2238 0.9999 
0.95 0.2107 1.0000 0.2332 0.9999 
0.9 0.2337 0.9999 0.2703 0.9999 
0.85 0.2467 0.9998 0.2916 0.9997 
0.8 0.2705 0.9998 0.2761 0.9992 


















Table 5. Comparison between theoretical [7] and empirical percolation and mass fraction 
parameters modelled. r refers to Pearson’s correlation coefficient. 
  Emcocel® Vivapur® 
Percolation coefficient 3.5 (empirical) 2.7 (theoretical) 3.5 (empirical) 2.7 (theoretical) 
pc(A) 0.180 0.267 0.200 0.288 
pc(B) 0.646 0.698 0.704 0.736 
r -0.970 -0.970 -0.938 -0.934  


















Figure 1. Particle size distribution of Emcocel® and Vivapur® samples measured by (a) Malvern 
Mastersizer 3000® and (b) Morphologi G3®. 
 
Figure 2. SEM images of (a) Vivapur® and (b) Emcocel®.  
 
Figure 3. Plot of bulk density of (a) ibuprofen, Emcocel® and Vivapur®, blends of (b) Emcocel®, and 
blends of (c) Vivapur ® under increasing consolidating stresses. 
 
Figure 4. Tabletability profiles of ibuprofen/MCC blends (a) Vivapur® and (b) Emcocel®. N=20, y-error 
bars indicate standard deviation. 
 
Figure 5. Tablet weight variation, expressed as percent relative standard deviation (%RSD) (n=280 
individual tablet weights).  
 
Figure 6. Linear correlation between tablets relative density (ρ) and σT^Tf, as represented by 
Equation 8. 
 
Figure 7.  Relationship between blends percolation threshold, pc(AB), and microcrystalline cellulose 
mass fraction, as represented by Equation 10. 
 
Figure 8. Tensile strength of Vivapur®/ibuprofen blends at different relative densities. A change in 
tensile strength behaviour was predicted to occur in the point of intersection of two linear 
fits, for each blend. 
 
Figure 9. Raman imaging of (a) Emcocel® and ibuprofen and (b) Vivapur® and ibuprofen blends. The 
areas in blue correspond to the excipient particles while the areas in white to API particles. 
The percentage express the % w/w of ibuprofen in the blend with MCC. 
 
Figure 10. Principle component Bi-plot (scores and loadings) for (a) PC-1 vs. PC-2 and (b) PC-2 vs. PC-
3, eigenvalues of 11.36, 2.71, and 1.17 for PC-1, PC-2, and PC-3, respectively. The ellipses 
around each group represents a 95% confidence interval. The squares represent the scores 

















 Modelling percolation threshold allows identification of critical drug loadings. 
 A percolation coefficient Tf= 3.5 was determined for blends of ibuprofen and MCC.  
 Calculated percolation threshold verified by testing desirable blend properties. 
 Raman imaging used to visualise drug loading for formation of infinite cluster. 


















Percolation theory provides a statistical model which can be used to predict the behaviour 
of powder blends based on particle-particle interactions. The aim of this study was to 
investigate if percolation theory could be used to predict the drug loading concentration of 
pharmaceutical tablets, and the relative density of a blend, above which tablet tensile 
strength is reduced, resulting in the production of unsatisfactory products.  The model blend 
studied contained ibuprofen as the API, which exhibits poor flow and compressibility, and 
microcrystalline cellulose (MCC) as the excipient, which exhibits good flowability and 
compressibility. Two MCC grades with differing physical properties were investigated, 
Vivapur® 102 (air streamed dried quality), and Emcocel® 90 (spray dried quality) to test the 
theory. Blends containing 2.5 to 40 % w/w of ibuprofen were compacted at a range of 
pressures and the values of the powder true density, compaction pressure, tablet envelope 
density, and tablet tensile strength were used to calculate the percolation thresholds 
mathematically. The drug loading threshold values predicted with the model (19.08% w/w 
and 17.76% w/w respectively for Vivapur® 102 and Emcocel® 90) were found to be in good 
agreement when compared to experimental data and the infinite cluster of drug was 
visually confirmed on the surface of tablets using Raman imaging. The capability of 
multivariate analysis to predict the drug loading threshold was also tested. Principal 
component analysis was unable to identify the threshold, but provided an overview of the 
changes of the analysed properties as ibuprofen drug loading increased. It was also able to 
identify differences between blends containing Vivapur® or Emcocel®. In conclusion, 
percolation theory was able to predict the maximum acceptable drug loading for this binary 
















to predict maximum drug loading potential without the need for time consuming and 
expensive tablet production. 
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